{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:40:29Z","timestamp":1738932029161,"version":"3.37.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.tcm.2024.08.001","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T19:24:35Z","timestamp":1722885875000},"page":"82-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial commentary: Evolving use of quinidine in the treatment of ventricular arrhythmias"],"prefix":"10.1016","volume":"35","author":[{"given":"Jeremy Y.","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4292-8061","authenticated-orcid":false,"given":"Sanjay","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tcm.2024.08.001_bib0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJM199801013380107","article-title":"Camm AJ. Quinidine","volume":"338","author":"Grace","year":"1998","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.tcm.2024.08.001_bib0002","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/archinte.158.19.2144","article-title":"Rate control and sinus rhythm maintenance in atrial fibrillation: national trends in Medication Use, 1980-1996","volume":"158","author":"Stafford","year":"1998","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.tcm.2024.08.001_bib0003","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199103213241201","article-title":"Mortality and morbidity in patients receiving encainide, flecainide, or placebo","volume":"324","author":"Echt","year":"1991","journal-title":"N Engl J Med"},{"issue":"40","key":"10.1016\/j.tcm.2024.08.001_bib0004","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2024.08.001_bib0005","article-title":"Quinidine for ventricular arrhythmias: a comprehensive review","author":"Rakza","year":"2024","journal-title":"Trends Cardiovasc Med"},{"issue":"7","key":"10.1016\/j.tcm.2024.08.001_bib0006","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jacc.2008.10.044","article-title":"Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization: role of drug therapy","volume":"53","author":"Ha\u00efssaguerre","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.tcm.2024.08.001_bib0007","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacep.2020.03.010","article-title":"Idiopathic ventricular fibrillation","volume":"6","author":"Ha\u00efssaguerre","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"24","key":"10.1016\/j.tcm.2024.08.001_bib0008","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jacc.2017.10.025","article-title":"Hydroquinidine prevents life-threatening arrhythmic events in patients with short QT syndrome","volume":"70","author":"Mazzanti","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2024.08.001_bib0009","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0033-0620(77)90004-4","article-title":"Adverse reactions to quinidine in hospitalized patients: findings based on data from the Boston collaborative drug surveillance program","volume":"20","author":"Cohen","year":"1977","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.tcm.2024.08.001_bib0010","unstructured":"Quinidine: Drug Information. In: Lexi-Drugs. UpToDate Inc. Accessed July 24, 2024. https:\/\/online.lexi.com"},{"issue":"2","key":"10.1016\/j.tcm.2024.08.001_bib0011","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.hrthm.2017.12.018","article-title":"Class IC antiarrhythmic drugs for suspected premature ventricular contraction\u2013induced cardiomyopathy","volume":"15","author":"Hyman","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.tcm.2024.08.001_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacep.2024.01.021","article-title":"Class 1C antiarrhythmics for premature ventricular complex suppression in nonischemic cardiomyopathy with implantable cardioverter-defibrillators","author":"Raad","year":"2024","journal-title":"Clin Electrophysiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173824000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173824000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T12:13:03Z","timestamp":1738930383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173824000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1050173824000744"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2024.08.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"type":"print","value":"1050-1738"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial commentary: Evolving use of quinidine in the treatment of ventricular arrhythmias","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2024.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}